logo
logo
Sign in

Clinical Trial Management System Market - Global Leaders and Different Growth Strategies Adopted by Them

avatar
Makarand Vaidya

Expected Revenue Surge:

The global clinical trial management system (CTMS) market is expected to grow at a CAGR of 12.6% between 2017 and 2022.

Growth Boosting Factors:

Factors such as significant partnerships between biopharma companies and CROs, rising number of clinical trials, availability of advanced CTMS solutions, growing customer base for CTMS solutions, and rising government funding & grants to support clinical trials are driving the overall demand for CTMS across key markets.

Global Leaders:

The major players operating in the clinical trial management system market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=470

Different Growth Strategies Adopted by Players:
 

Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the CTMS market.

Among these business strategies, product enhancements, agreements, and partnerships were the most widely adopted growth strategies by the players in the CTMS market.

Oracle (US) held the leading position in the global CTMS market in 2016. The company is one of the top players in the CTMS market due to its diversified geographic presence and large customer base, strong brand image, and selective and active acquisition program and alliances. The company offers cloud-based CTMS. The company has a strong geographic presence in over 175 countries across North America, Europe, Asia, Africa, and South America. 

The company mainly focuses on expansions and acquisitions to strengthen its dominant position in the market. For instance, in 2017, Oracle opened its Oracle Cloud EU Region in Germany, with the addition of modern infrastructure as a service (IaaS) architecture and new IaaS and platform as a service (PaaS) cloud services.

Medidata Solutions, Inc. (US) held the second position in the CTMS market in 2016. The company is one of the leading providers of cloud (software-as-a-service) solutions and has strong partnerships with CROs and pharmaceutical customers. Medidata is present in more than 130 countries with more than 849 customers across the globe. The company primarily adopts the strategy of partnerships to expand its presence in the CTMS market. In 2017, the company partnered with Karyopharm Therapeutics (US) to renew its Medidata Clinical Cloud platform.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=470

Geographical Growth Scenario:

North America is expected to dominate the CTMS market during the forecast period

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2027). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

collect
0
avatar
Makarand Vaidya
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more